Cargando…
Molecular signatures in the progression of COVID-19 severity
SARS-CoV-2 is the causative agent of COVID-19 that has infected over 642 million and killed over 6.6 million people around the globe. Underlying a wide range of clinical manifestations of this disease, from moderate to extremely severe systemic conditions, could be genes or pathways differentially e...
Autores principales: | De, Ronika, Azad, Rajeev K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9768786/ https://www.ncbi.nlm.nih.gov/pubmed/36543855 http://dx.doi.org/10.1038/s41598-022-26657-2 |
Ejemplares similares
-
Analysis of transcribed sequences from young and mature zebrafish thrombocytes
por: Fallatah, Weam, et al.
Publicado: (2022) -
The Arabidopsis gene co‐expression network
por: Burks, David J., et al.
Publicado: (2022) -
Severe COVID-19 induces molecular signatures of aging in the human brain
por: Mavrikaki, Maria, et al.
Publicado: (2021) -
Identification of PBMC-based molecular signature associational with COVID-19 disease severity
por: Shaath, Hibah, et al.
Publicado: (2021) -
A distinct innate immune signature marks progression from mild to severe COVID-19
por: Chevrier, Stéphane, et al.
Publicado: (2020)